Article
YY1: a key regulator inhibits gastric cancer ferroptosis and mediating Apatinib-resistance
2023-05-30
Abstract excerpt
<h4>Background: </h4> Gastric cancer (GC) is one of the most common and lethal cancers worldwide. Apatinib, a preoperative neoadjuvant therapy, has limited efficacy in GC patients with high YY1 expression. YY1 is associated with poor prognosis, drug resistance and metastasis in GC, but its mechanisms are unclear. Results We observed that higher YY1 expression levels were associated with lower postoperative progre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c158b02f-bb63-5b97-8ab0-fb89645ae03c
- DOI
- 10.21203/rs.3.rs-2993818/v1